VIVA BIOTECH(01873),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

01873 VIVA BIOTECH

Closed 02-11 16:08:13

2.380

-0.020

-0.83%

High2.430	Low2.350	Vol5.72M
Open2.420	D1 Closing2.400	Amplitude3.33%
Mkt Cap5.07B	Tradable Cap5.07B	Total Shares2.13B
T/O13.68M	T/O Rate0.27%	Tradable Shares2.13B
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.

{"stockData":{"symbol":"01873","market":"HK","secType":"STK","nameCN":"VIVA BIOTECH","latestPrice":2.38,"timestamp":1770797293002,"preClose":2.4,"halted":0,"volume":5715500,"delay":0,"changeRate":-0.008333333333333342,"floatShares":2130000000,"shares":2130000000,"eps":0.06783051165408245,"marketStatus":"Closed","change":-0.02,"latestTime":"02-11 16:08:13","open":2.42,"high":2.43,"low":2.35,"amount":13677023,"amplitude":0.033333,"askPrice":2.39,"askSize":20500,"bidPrice":2.38,"bidSize":3000,"shortable":3,"etf":0,"ttmEps":0.10061525895355564,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1770859800000},"marketStatusCode":5,"adr":0,"listingDate":1557331200000,"exchange":"SEHK","adjPreClose":2.4,"openAndCloseTimeList":[[1770773400000,1770782400000],[1770786000000,1770796800000]],"volumeRatio":0.710353,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/01873/tweets","defaultTab":"tweets","newsList":[{"id":"1176500753","title":"CRO Stocks Lead Gains as Biopharma Investment and Cross-Border Deals Rebound","url":"https://stock-news.laohu8.com/highlight/detail?id=1176500753","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1176500753?lang=en_us&edition=fundamental","pubTime":"2026-02-10 10:58","pubTimestamp":1770692300,"startTime":"0","endTime":"0","summary":"CRO concept stocks are leading the gains in Hong Kong trading. By the time of writing, VIVA BIOTECH (01873) rose 6.14% to HK$2.42, WUXI BIO (02269) increased 6.01% to HK$40.54, TIGERMED (03347)...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0052750758.USD","LU0456846285.SGD","SG9999002463.SGD","LU0417516902.SGD","LU0051755006.USD","LU1688375341.USD","LU0417516738.SGD","01873","IE00B0JY6N72.USD","LU2125910500.SGD","LU2039709279.SGD","VT","03347","LU0348825331.USD","LU0307460666.USD","LU1794554557.SGD","LU1880383366.USD","LU0181495838.USD","BK1583","LU0516422440.USD","LU0708995583.HKD","BK4585","LU0320764599.SGD","LU0572944931.SGD","LU0326950275.SGD","LU1242518931.SGD","LU0140636845.USD","LU3063872942.SGD","LU2242644610.SGD","BK1589","LU0359202008.SGD","LU1046422090.SGD","BK1161","LU0588546209.SGD","LU1242518857.USD","SG9999002562.SGD","BK1574","LU1720050803.USD","159992","BK1610","LU0516422952.EUR","LU0516423091.SGD","LU0456827905.SGD","VXUS","LU0043850808.USD","02269","LU0823426308.USD","LU0327786744.USD","LU0348735423.USD","02359","LU0819121731.USD","LU0823426480.USD","LU0856984785.SGD","LU0516422366.SGD","LU2045819591.USD","LU0359201612.USD","06978","LU0039217434.USD","LU0516423174.USD","BK4588","BK1521","BK1576","LU0979878070.USD","BK1141"],"gpt_icon":0},{"id":"1140170464","title":"VIVA BIOTECH (01873): Langhua Pharmaceutical's Environmental Impact Report Gains Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1140170464","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140170464?lang=en_us&edition=fundamental","pubTime":"2026-01-29 19:26","pubTimestamp":1769685995,"startTime":"0","endTime":"0","summary":"VIVA BIOTECH (01873) announced that its wholly-owned subsidiary, Zhejiang Langhua Pharmaceutical Co., Ltd., recently received a response from the Taizhou Municipal Bureau of Ecology and Environment...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873","BK1191","BK1576","BK1574","01477","BK1141"],"gpt_icon":0},{"id":"2607086347","title":"Langhua Pharmaceutical Wins Approval to Expand Peptide Production","url":"https://stock-news.laohu8.com/highlight/detail?id=2607086347","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2607086347?lang=en_us&edition=fundamental","pubTime":"2026-01-29 19:21","pubTimestamp":1769685661,"startTime":"0","endTime":"0","summary":"Zhejiang Langhua Pharmaceutical Co., Ltd., a wholly-owned subsidiary of VIVA Biotech Holdings, has received approval from the Taizhou Ecological Environment Bureau for its environmental impact report. The approval allows Langhua Pharmaceutical to remodel three existing plants in Linhai Park, Zhejiang Province, for the production of peptides and advanced intermediates for other small-molecule drugs. The company plans to implement the approved production plans to support business growth and increase production capabilities and capacities.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VIVA Biotech Holdings published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Sto","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260129:nNDLwKKpw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","BK1141","01873"],"gpt_icon":0},{"id":"2605064284","title":"Viva Biotech Holdings' (HKG:1873) Shares Bounce 28% But Its Business Still Trails The Industry","url":"https://stock-news.laohu8.com/highlight/detail?id=2605064284","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2605064284?lang=en_us&edition=fundamental","pubTime":"2026-01-24 06:52","pubTimestamp":1769208755,"startTime":"0","endTime":"0","summary":"Viva Biotech Holdings ( HKG:1873 ) shareholders are no doubt pleased to see that the share price has bounced 28% in the...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1873/viva-biotech-holdings-shares/news/viva-biotech-holdings-hkg1873-shares-bounce-28-but-its-busin","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1873/viva-biotech-holdings-shares/news/viva-biotech-holdings-hkg1873-shares-bounce-28-but-its-busin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["VBIZF","BK1576","LABU","BK4588","BK1141","01873","BK4585","BK4121"],"gpt_icon":0},{"id":"1190646443","title":"VIVA BIOTECH (01873) Surges Over 18% in Late Trading, Driven by AI-Powered R&D Efficiency and Investment Incubation Ecosystem","url":"https://stock-news.laohu8.com/highlight/detail?id=1190646443","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1190646443?lang=en_us&edition=fundamental","pubTime":"2026-01-23 15:56","pubTimestamp":1769155002,"startTime":"0","endTime":"0","summary":"VIVA BIOTECH (01873) surged more than 18% in late trading. As of the time of writing, the stock was up 18.09%, trading at HK$2.35, with a turnover of HK$64.7058 million.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1576","BK1610","02800","01873"],"gpt_icon":0},{"id":"1130193302","title":"VIVA BIOTECH (01873) Surges Nearly 7% Intraday as Innovation Symposium Showcases New R&D Pathways","url":"https://stock-news.laohu8.com/highlight/detail?id=1130193302","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130193302?lang=en_us&edition=fundamental","pubTime":"2026-01-22 15:08","pubTimestamp":1769065701,"startTime":"0","endTime":"0","summary":"VIVA BIOTECH (01873) saw its shares climb nearly 7% during the trading session. As of the time of writing, the stock was up 4.21%, trading at HKD 1.98, with a turnover of HKD 16.048 million....","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1610","BK4585","BK1576","02800","BK4588","399441","01873","LABU","BK1141","161726"],"gpt_icon":1},{"id":"2602559589","title":"Asian Penny Stocks To Watch In January 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2602559589","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602559589?lang=en_us&edition=fundamental","pubTime":"2026-01-12 06:01","pubTimestamp":1768168911,"startTime":"0","endTime":"0","summary":"As 2026 begins, Asian markets are capturing attention with their dynamic movements, particularly as investors navigate the broader global economic landscape. Penny stocks, though often seen as a niche investment area, continue to hold potential for those seeking value and growth in smaller or newer companies. Despite being an older term, penny stocks can still offer significant opportunities when backed by strong financial health; here we explore a few that stand out for their promising...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/3112100-choice2-main-header/1585186903084","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/3112100-choice2-main-header/1585186903084"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/real-estate-management-and-development/hkg-2869/greentown-service-group-shares/news/asian-penny-stocks-to-watch-in-january-2026-3","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/real-estate-management-and-development/hkg-2869/greentown-service-group-shares/news/asian-penny-stocks-to-watch-in-january-2026-3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU1242518857.USD","SG9999013460.SGD","5UL.SI","LIC.NZ","SG9999004360.SGD","SG9999013486.USD","02869","LU0516423174.USD","LU1242518931.SGD","01346","BK6504","BK4139","SG9999003826.SGD","SGXZ24219693.SGD","SG9999000343.SGD","LU0164939612.USD","SGXZ43160589.SGD","BK6065","BK8052","LU0516422440.USD","SG9999014484.SGD","BK8040","BK8065","HQU.SI","SCT.NZ","01948","SG9999000475.SGD","SGXZ58947870.SGD","LU0082770016.USD","LU0516423091.SGD","02283","01873","NGCRY","SG9999002679.SGD","BK6045","03918","03998","SG9999013478.USD","BK1137","SGXZ27511609.SGD","LU0516422952.EUR","SG9999014492.USD","LU0082770016.SGD","BSDGY","BS6.SI","LU0979878070.USD","LU0516422366.SGD","LU0620787316.HKD","SG9999016042.SGD"],"gpt_icon":1},{"id":"2602586388","title":"Viva Biotech Holdings (HKG:1873) shareholder returns have been strong, earning 143% in 1 year","url":"https://stock-news.laohu8.com/highlight/detail?id=2602586388","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602586388?lang=en_us&edition=fundamental","pubTime":"2026-01-10 08:03","pubTimestamp":1768003431,"startTime":"0","endTime":"0","summary":"The last three months have been tough on Viva Biotech Holdings ( HKG:1873 ) shareholders, who have seen the share price...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551728-choice2-main-header/1585186774276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1873/viva-biotech-holdings-shares/news/viva-biotech-holdings-hkg1873-shareholder-returns-have-been","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-1873/viva-biotech-holdings-shares/news/viva-biotech-holdings-hkg1873-shareholder-returns-have-been","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4121","VBIZF","BK1576","BK1141","01873"],"gpt_icon":0},{"id":"2601000746","title":"BRIEF-Viva Biotech Received Declaration Letter","url":"https://stock-news.laohu8.com/highlight/detail?id=2601000746","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601000746?lang=en_us&edition=fundamental","pubTime":"2026-01-05 18:02","pubTimestamp":1767607374,"startTime":"0","endTime":"0","summary":"BRIEF-Viva Biotech Received Declaration LetterJan 5  - VIVA Biotech Holdings 1873.HK:RECEIVED DECLARATION LETTER FROM EACH OF HLC SPV, QINGDAO HONGYI, DAXUE INVESTMENTS AND TRUE LIGHT P AND RAED CAPITAL HOLDINGS 2LETTER TO TEMPORARILY SUSPEND RIGHT TO REQUIRE THE OBLIGORS TO  REPURCHASE STAKE IN HLC SPV, OTHERSFurther company coverage: 1873.HK ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nFWN3Y60GV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","01873","BK1576"],"gpt_icon":0},{"id":"2601071300","title":"VIVA Biotech Investors Suspend Repurchase Rights for Shanghai VIVA Equity","url":"https://stock-news.laohu8.com/highlight/detail?id=2601071300","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601071300?lang=en_us&edition=fundamental","pubTime":"2026-01-05 17:59","pubTimestamp":1767607150,"startTime":"0","endTime":"0","summary":"VIVA Biotech Holdings has provided an update regarding the disposal of an equity interest in its subsidiary, VIVA Shanghai, to a group of institutional investors. According to the announcement, the investors, including HLC SPV, Qingdao Hongyi, Daxue Investments, True Light P, and Raed Capital Holdings 2 Ltd, hold minority shares in VIVA Shanghai as a result of a previous transaction. Under the terms of the Shareholders Agreement, these investors have the right to require VIVA Shanghai, VIVA Biotech Holdings, and related parties to repurchase their equity interest if VIVA Shanghai does not complete a qualified IPO or achieve a qualified merger and acquisition transaction by December 31, 2026. However, the investors have agreed to temporarily suspend their right to enforce the repurchase obligation during the period between December 31, 2026, and December 31, 2028, due to prevailing market conditions and ongoing business and capital raising plans for VIVA Shanghai. All other terms of the","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nNDL2QkR62:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","01873","BK1576"],"gpt_icon":0},{"id":"2601100769","title":"VIVA Biotech - Received Declaration Letter From Each of Hlc Spv, Qingdao Hongyi, Daxue Investments and True Light P and Raed Capital Holdings 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2601100769","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601100769?lang=en_us&edition=fundamental","pubTime":"2026-01-05 17:59","pubTimestamp":1767607143,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nFWN3Y60GV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1576","BK1141","01873"],"gpt_icon":0},{"id":"2601007634","title":"VIVA Biotech -  Letter to Temporarily Suspend Right to Require the Obligors to  Repurchase Stake in Hlc Spv, Others","url":"https://stock-news.laohu8.com/highlight/detail?id=2601007634","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601007634?lang=en_us&edition=fundamental","pubTime":"2026-01-05 17:59","pubTimestamp":1767607143,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nFWN3Y60GV:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK1141","01873","BK1576"],"gpt_icon":0},{"id":"2595204152","title":"Viva Biotech Expands Pharmacology Platform to Support Diverse Drug Modalities","url":"https://stock-news.laohu8.com/highlight/detail?id=2595204152","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595204152?lang=en_us&edition=fundamental","pubTime":"2025-12-29 14:14","pubTimestamp":1766988848,"startTime":"0","endTime":"0","summary":"Viva Biotech Holdings has expanded its capabilities by strengthening its integrated pharmacology platform, enhancing its Drug Metabolism and Pharmacokinetics , pharmacology, and efficacy services. The company has invested in facility expansion and deeper integration of antibody pharmacokinetics with disease-focused studies across multiple therapeutic areas. This comprehensive platform now supports a wide range of drug modalities, offering end-to-end services from structure-based discovery to IND filing and enabling more data-driven decisions in preclinical drug development.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VIVA Biotech Holdings published the original content used to generate this news brief via PR Newswire  on December 29","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251229:nNDLbL7Yfz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","01873","BK1576"],"gpt_icon":0},{"id":"1107411470","title":"Hong Kong Stocks Movement | CRO Concept Stocks Under Pressure: PHARMARON (03759) Drops Over 4%, JOINN (06127) Falls Over 3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1107411470","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107411470?lang=en_us&edition=fundamental","pubTime":"2025-12-22 15:32","pubTimestamp":1766388737,"startTime":"0","endTime":"0","summary":"CRO concept stocks faced downward pressure in Hong Kong trading. As of press time, PHARMARON (03759) declined 4.32% to HK$21.24, while JOINN (06127) fell 3.29% to HK$21.16. ASYMCHEM (06821) dropped...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06127","01873","300759","BK1141","03759","BK1191","BK1576","06821","603127","BK0216"],"gpt_icon":0},{"id":"1165182041","title":"$40 Million Investment Gain Fails to Prevent Intraday 15% Plunge: What's VIVA BIOTECH (01873) Worth Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=1165182041","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1165182041?lang=en_us&edition=fundamental","pubTime":"2025-12-15 20:30","pubTimestamp":1765801837,"startTime":"0","endTime":"0","summary":"On the evening of December 14, VIVA BIOTECH (01873) announced that Swedish Orphan Biovitrum AB (\"Sobi\") had entered into an acquisition agreement with Arthrosi, a company incubated through VIVA...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","01873","BK1141"],"gpt_icon":0},{"id":"2591690511","title":"VIVA Biotech's Invested and Incubated Company, Arthrosi, Has Entered Into an Acquisition Agreement With Sobi for a Total Transaction Value of up to US$1.5 Billion.","url":"https://stock-news.laohu8.com/highlight/detail?id=2591690511","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591690511?lang=en_us&edition=fundamental","pubTime":"2025-12-15 14:06","pubTimestamp":1765778786,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251215:nTUA8MB7VG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["01873","BK1141","BK1576"],"gpt_icon":0},{"id":"1137751292","title":"Hong Kong Stocks Movement | VIVA BIOTECH (01873) Surges Over 13% as Investee Arthrosi Reaches Acquisition Deal with Sobi","url":"https://stock-news.laohu8.com/highlight/detail?id=1137751292","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137751292?lang=en_us&edition=fundamental","pubTime":"2025-12-15 09:38","pubTimestamp":1765762695,"startTime":"0","endTime":"0","summary":"VIVA BIOTECH (01873) rose more than 13%, reaching HK$2.2 by the time of writing, with a turnover of HK$4.82 million. The surge follows news on December 13 that Swedish Orphan Biovitrum AB (Sobi), a...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1576","01873","BK1141"],"gpt_icon":0},{"id":"1166210762","title":"VIVA BIOTECH (01873) Divests Stake in an Investment Incubator Company","url":"https://stock-news.laohu8.com/highlight/detail?id=1166210762","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166210762?lang=en_us&edition=fundamental","pubTime":"2025-12-14 19:22","pubTimestamp":1765711334,"startTime":"0","endTime":"0","summary":"VIVA BIOTECH (01873) announced that Arthrosi Therapeutics has informed the company that on December 13, 2025, the buyer, Sobi US Holding Corp., agreed to acquire Arthrosi Therapeutics through a...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","01873","BK1576"],"gpt_icon":0},{"id":"2591366366","title":"VIVA Biotech Sells Minority Stake in Arthrosi Therapeutics for Up to US$1.5 Billion","url":"https://stock-news.laohu8.com/highlight/detail?id=2591366366","media":"Reuters","labels":["shareholding","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591366366?lang=en_us&edition=fundamental","pubTime":"2025-12-14 19:11","pubTimestamp":1765710718,"startTime":"0","endTime":"0","summary":"Viva Biotech Holdings announced that its wholly-owned subsidiary, Viva Incubator, has agreed to dispose of its minority equity interest in Arthrosi Therapeutics. The transaction will occur through a merger in which Sobi US Holding Corp. will acquire Arthrosi Therapeutics. Under the terms of the merger agreement, Viva Biotech Holdings will receive an upfront payment of US$950 million at closing, subject to customary adjustments, and may receive additional contingent consideration of up to US$550 million. Following the completion of the merger, Viva Biotech Holdings will no longer hold any equity interest in Arthrosi Therapeutics.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. VIVA Biotech Holdings published the original content used to ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251214:nNDL2GSY3t:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"VIVA Biotech Sells Minority Stake in Arthrosi Therapeutics for Up to US$1.5 Billion","news_tag":"shareholding,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873","BK1576","BK1141"],"gpt_icon":0},{"id":"1166395462","title":"Viva Biotech Holdings (1873) Announces Grant of 8.58 Million Share Options","url":"https://stock-news.laohu8.com/highlight/detail?id=1166395462","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1166395462?lang=en_us&edition=fundamental","pubTime":"2025-12-02 19:24","pubTimestamp":1764674652,"startTime":"0","endTime":"0","summary":"Viva Biotech Holdings (1873) issued an announcement on December 2, 2025, regarding the grant of 8,580,000 share options to employees under its Post-IPO Share Option Scheme. The exercise price was set...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01873"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.vivabiotech.com","stockEarnings":[{"period":"1week","weight":0.0213},{"period":"1month","weight":0.2371},{"period":"3month","weight":0.106},{"period":"6month","weight":-0.0164},{"period":"1year","weight":1.5532},{"period":"ytd","weight":0.3333}],"compareEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":0.0363},{"period":"3month","weight":0.0097},{"period":"6month","weight":0.0652},{"period":"1year","weight":0.263},{"period":"ytd","weight":0.0606}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"VIVA Biotech Holdings is an investment holding company. The Company has two segments. The Drug Discovery Services segment provides structure-based drug discovery services to biotech and pharmaceutical clients for preclinical innovative drug development. The Contract Design and Manufacturing (CDMO) and Commercialization Services segment is engaged in contract development and manufacturing services for small molecule Active Pharmaceutical Ingredients (APIs) and intermediates, as well as the trading of APIs, intermediates and finished products. The Company conducts business primarily in the United States, China, Europe and other regions.","yearOnYearQuotes":[{"month":1,"riseRate":0.285714,"avgChangeRate":-0.080145},{"month":2,"riseRate":0.285714,"avgChangeRate":0.02952},{"month":3,"riseRate":0.333333,"avgChangeRate":0.02465},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.020806},{"month":5,"riseRate":0.666667,"avgChangeRate":0.245742},{"month":6,"riseRate":0.285714,"avgChangeRate":-0.034299},{"month":7,"riseRate":0.714286,"avgChangeRate":0.010126},{"month":8,"riseRate":0.428571,"avgChangeRate":0.041644},{"month":9,"riseRate":0.285714,"avgChangeRate":0.021762},{"month":10,"riseRate":0.428571,"avgChangeRate":-0.044725},{"month":11,"riseRate":0.142857,"avgChangeRate":-0.040545},{"month":12,"riseRate":0.571429,"avgChangeRate":0.026236}],"exchange":"SEHK","name":"VIVA BIOTECH","nameEN":"VIVA BIOTECH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"VIVA BIOTECH(01873),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest VIVA BIOTECH(01873) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"VIVA BIOTECH,01873,VIVA BIOTECH股票,VIVA BIOTECH股票老虎,VIVA BIOTECH股票老虎国际,VIVA BIOTECH行情,VIVA BIOTECH股票行情,VIVA BIOTECH股价,VIVA BIOTECH股市,VIVA BIOTECH股票价格,VIVA BIOTECH股票交易,VIVA BIOTECH股票购买,VIVA BIOTECH股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"VIVA BIOTECH(01873),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest VIVA BIOTECH(01873) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}